美通社

2024-11-19 20:29

Xinhua Silk Road: Inheriting traditions while promoting innovation, Chinese pharmaceutical company contributes to TCM globalization

BEIJING, Nov. 19, 2024 /PRNewswire/ -- With continuous advancement of the Belt and Road Initiative, Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. has been actively promoting the globalization of traditional Chinese medicine (TCM) through both inheriting traditional assets and engaging in modern innovations.

The company, based in southeast China's Fujian Province, has been making continuing efforts in recent years to improve the influence of TCM in Southeast Asia, Europe and other regions, as well as to increase international recognition of TCM through deepened international exchanges and cooperation.

Striving to expand its overseas market, the company has also visited Brazil, Argentina and other countries to inspect the market environment. The company was announced as one of the favorite Chinese brands among foreigners during this year's China Brand Day events.

The core product of the company, Pien Tze Huang, is listed as a national protected variety of TCM, with its traditional production techniques included as a national intangible cultural heritage and its export volume ranking among the top for many years amidst single varieties of Chinese patent medicine.

In old times, Pien Tze Huang used to be brought by the merchant teams from Zhangzhou to all around the world through the ancient Maritime Silk Road. Nowadays, the product is sold to a number of countries and regions including Singapore, Thailand, Indonesia, Malaysia, Canada and so on.

In order to meet the requirements of TCM globalization in the new era, the Chinese pharmaceutical company has continuously strengthened its scientific research capabilities in recent years, carrying out more than 30 original and integrated innovation studies in cooperation with research institutions.

In March this year, the China Association of Chinese Medicine announced that the revealing of the clinical efficacy mechanism of Pien Tze Huang had been selected as one of the top ten academic advances in the field of TCM in 2023, which is greatly conducive to improving international recognition of the product.

In the future, the company is committed to spreading the culture of TCM, opening up a broader global market, and continuing to contribute the wisdom of ancient Chinese medicine to the health of people around the world.

Original link: https://en.imsilkroad.com/p/343190.html

 

source: Xinhua Silk Road

【香港好去處】2025去邊最好玩?etnet為你提供全港最齊盛事活動,所有資訊盡在掌握!► 即睇

人氣文章
最近7天
1
港股 | 蕭猷華:內地AI發展迅速,阿里巴巴股價看俏
2
PapaHome淘寶家具實體店22日開幕,選址尖沙咀中港城,料創100個就業機會
3
高息定存 | 華僑銀行推新春港元定存優惠,88天或188天享3.68厘
4
財政預算案2025 | 重點文字直播/Youtube直播(稍後送上懶人包)
5
高息定存 | 一周高息合集,蛇年定存金蛇起舞,1個月定存高達8厘
6
高息定存 | 一周高息合集,3個月5厘之選有邊間?6個月最高3.55厘
7
啟德體育園明天足球賽測試,4.4萬公僕參與涉逾400萬車馬費
8
環球央行 | 歐洲央行宣布再次減息0.25厘,符合市場預期
9
高息定存 | 一周高息合集,減息預期降溫,銀行3個月最高5.68厘,6個月3.55厘
10
專訪 | 關稅戰 | 香港物流協會副會長梁庭彰:美物流商停收包裹對跨境電商打擊重大
11
易經看世界 | 乙巳蛇年趨吉五招:言行注意甚麼?應遠離甚麼人?(有片)
12
港股 | 午市前瞻 | iPhone SE難救中國市場 專家提醒比電已超買
13
【FOCUS】悟空、哪吒、DeepSeek,如何啟示香港
14
大S | 台灣藝人徐熙媛因流感併發肺炎逝世,享年48歲
15
收市短打 | 楊韻銳:港股升勢有成交配合 惟留意關鍵阻力位!
16
日入而息 | 習近平據報下周見科企領袖,證監會審視8券商孖展風控,大酒店轉蝕9億
17
高息定存 | 信銀國際12個月港元定存高達3.5厘
18
彭博亞洲20大富裕家族,香港5大家族上榜,新地郭氏排名最高,無李嘉誠李兆基?
19
港股 | 午市前瞻 | AI應用概念炒作有錢途 下階段部署邊隻好?
20
民營企業座談會 | 習近平在京出席民營企業座談會
21
David Webb:因病情惡化,將有序結束個人財經網站
22
AI | 追捧DeepSeek,全球對沖基金棄印度投中國
23
AI | 蔡崇信確認阿里與蘋果合作,撰文談DeepSeek崛起帶來兩大啟示
24
神州經脈 | 習近平:經濟政策不會變,民企大顯身手正當其時
25
譚仔 | 譚仔國際日資大股東溢價76%建議私有化今復牌,上市不足三年半
26
港股 | 蕭猷華:恒指升勢可持續?
27
比特幣 | 亞洲時段虛擬貨幣大幅下跌,31萬人爆倉
28
美股收盤 | 美股三大指數收市報跌,道指跌近750點
29
2025強積金整合獎賞一覽 轉供應商最多竟然可賺!?
30
神州經脈 | 中國減持美債,螞蟻入局具身智能,70城樓價向好
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

etnet榮膺「第九屆傳媒轉型大獎」四大獎項

【限時優惠$68/月】申請etnet強化版MQ手機串流報價服務 捕捉板塊輪動,提高獲利勝算

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

2025-26年度財政預算案

大國博弈

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老